March 24, 2010 (FinancialWire) — BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) reported that the company’s GVAX leukemia vaccine reduced or eliminated the remaining cancer cells in some CML patients taking Gleevec, demonstrating that after a median follow-up of 72 months, the number of remaining cancer cells declined in 13 patients, 8 of whom had increasing disease burden before vaccination.

Other recent FinancialWire(tm) news items pertaining to the oncology and stem cell sectors today include Cell Therapeutics, Inc. (NASDAQ: CTIC) go to http://www.financialwire.net/?s=%22%28NASDAQ%3A+CTIC%29%22), BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) (go to http://www.financialwire.net/?s=%22%28NASDAQ%3A+BPAX%29%22), Myriad Genetics, Inc. (NASDAQ: MYGN) (go to http://www.financialwire.net/?s=%22%28NASDAQ%3A+MYGN%29%22), Nektar Therapeutics (NASDAQ: NKTR) (go to http://www.financialwire.net/?s=%22%28NASDAQ%3A+NKTR%29%22), Genomic Health, Inc. (NASDAQ: GHDX) (go to http://www.financialwire.net/?s=%22%28NASDAQ%3A+GHDX%29%22), Entest BioMedical, Inc. (OTCBB: ENTB) (go to http://www.financialwire.net/?s=%22%28OTCBB%3A+ENTB%29%22), and others.

Source: Zangani Investor Community (http://www.investrend.com/about/zangani).

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Source of original content for this article: (http://www.zangani.com/node/4024).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.